CVS Health (NYSE:CVS) Shares Gap Down After Analyst Downgrade

Key Points

• Bank of America cut its price target on CVS from $100 to $95 but kept a Buy rating; the stock gapped down from $83.87 to an open of $75.39 and last traded around $74.74, down about 11.5% on heavy volume.
• Analyst consensus remains a Moderate Buy (20 Buys, 4 Holds) with an average target of $94.86, and CVS reported a quarterly beat and set FY2025 guidance of $6.55–$6.65 EPS.
• Key near‑term risks driving negative sentiment are the administration’s proposal for near‑flat Medicare Advantage rates, which pressures PBM/insurer revenue, and a House Judiciary antitrust probe into CVS’ pharmacy practices that raises regulatory and legal uncertainty.

CVS Health Corporation (NYSE:CVS - Get Free Report)'s stock price gapped down before the market opened on Tuesday after Bank of America lowered their price target on the stock from $100.00 to $95.00. The stock had previously closed at $83.87, but opened at $75.39. Bank of America currently has a buy rating on the stock. CVS Health shares last traded at $74.7420, with a volume of 11,895,453 shares changing hands.

A number of other equities analysts also recently commented on the stock. Mizuho upped their target price on shares of CVS Health from $88.00 to $95.00 and gave the stock an "outperform" rating in a research note on Wednesday, December 10th. Cantor Fitzgerald restated an "overweight" rating on shares of CVS Health in a research note on Wednesday, December 10th. Leerink Partners raised their target price on CVS Health from $86.00 to $95.00 and gave the stock an "outperform" rating in a research note on Thursday, October 16th. Wall Street Zen lowered CVS Health from a "buy" rating to a "hold" rating in a report on Saturday, November 1st. Finally, Wells Fargo & Company lowered their target price on shares of CVS Health from $103.00 to $102.00 and set an "overweight" rating on the stock in a research note on Thursday, November 13th. Twenty investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $94.86.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Neutral Sentiment: Analyst forecasts page shows updated price-targets and consensus projections that investors will watch for guidance changes after recent headlines. CVS Health Corporation (CVS) Stock Forecasts
• Neutral Sentiment: Zacks notes CVS is a trending ticker and flags fundamentals and recent attention — useful background but not new catalysts. CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
• Neutral Sentiment: Zacks Analyst Blog mention (broader market context); not a direct CVS catalyst but part of investor chatter. The Zacks Analyst Blog Microsoft, Anheuser-Busch CVS, and Stran & Co
• Negative Sentiment: Barron’s reports Humana, UnitedHealth and CVS shares plunged after the administration proposed keeping Medicare Advantage rates roughly flat, which trims revenue expectations for insurers and PBMs. Humana, UnitedHealth, and CVS Stocks Plunge After Medicare Rates Blow
• Negative Sentiment: CNBC: investors sold health insurers and related stocks in extended trading after the Trump administration proposed nearly flat Medicare Advantage rates, hitting CVS shares hard. Health insurers tumble after Trump administration proposes keeping Medicare Advantage rates flat next year
• Negative Sentiment: Reuters reports the administration’s draft would raise payments to insurers by roughly 0.09% on average — a near-flat change that lowers the revenue outlook for MA players and PBMs like CVS Caremark. Trump Administration proposes keeping steady Medicare rates paid to insurers, WSJ reports
• Negative Sentiment: Investing.com coverage highlights the market reaction: CVS and other health names tumbled on the lower Medicare rate proposal, signaling investor worry about near-term top-line pressure. CVS Health, UnitedHealth Group stocks tumble on lower Medicare rate proposal
• Negative Sentiment: HealthCareDive reports a House Judiciary investigation alleges CVS shut out rival pharmacy hubs — increasing regulatory and legal risk that could pressure margins and contracts. CVS accused of shutting out rival pharmacy hubs in House Judiciary investigation
• Negative Sentiment: FierceHealthcare summarizes a House report alleging CVS sought to stifle pharmacy-hub competition — a potential source of fines, contract limits, or remediation that investors will watch. House report alleges CVS aimed to stifle pharmacy hub competition
• Negative Sentiment: BizJournal profile notes CVS is simultaneously positioning as a healthcare partner while fighting Congress, the FTC and courts — reinforcing regulatory uncertainty for investors. Woonsocket-based CVS battles Congress, FTC and courts while positioning itself as healthcare reform partner

Institutional Trading of CVS Health

Several institutional investors and hedge funds have recently bought and sold shares of the business. Cantor Fitzgerald Investment Advisors L.P. boosted its stake in shares of CVS Health by 1.6% during the 2nd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator's stock worth $28,264,000 after buying an additional 6,615 shares during the last quarter. Alpha Omega Wealth Management LLC boosted its position in CVS Health by 12.3% during the third quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator's stock valued at $11,301,000 after purchasing an additional 16,418 shares during the last quarter. Aaron Wealth Advisors LLC grew its stake in CVS Health by 177.4% in the third quarter. Aaron Wealth Advisors LLC now owns 34,259 shares of the pharmacy operator's stock valued at $2,583,000 after purchasing an additional 21,911 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of CVS Health by 186.6% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator's stock worth $30,568,000 after purchasing an additional 258,050 shares during the last quarter. Finally, Red Mountain Financial LLC bought a new stake in shares of CVS Health during the 2nd quarter worth approximately $293,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Stock Down 11.5%

The firm has a market capitalization of $94.21 billion, a P/E ratio of 195.50, a PEG ratio of 0.76 and a beta of 0.48. The firm's 50 day moving average is $79.17 and its two-hundred day moving average is $74.97. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating analysts' consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to analysts' expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company's revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter last year, the company posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Research analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be given a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.6%. CVS Health's dividend payout ratio is presently 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.